SHWZ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SHWZ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Medicine Man Technologies's Enterprise Value for the quarter that ended in Jun. 2024 was $217.5 Mil. Medicine Man Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-8.6 Mil. Medicine Man Technologies's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2024 was -3.94%.
The historical rank and industry rank for Medicine Man Technologies's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
During the past 10 years, the highest Earnings Yield (Joel Greenblatt) of Medicine Man Technologies was 37.69%. The lowest was -49.91%. And the median was -2.69%.
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Medicine Man Technologies's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2024 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
The historical data trend for Medicine Man Technologies's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicine Man Technologies Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Earnings Yield (Joel Greenblatt) % | Get a 7-Day Free Trial |
![]() |
![]() |
-14.12 | -24.39 | 32.89 | 14.20 | 7.94 |
Medicine Man Technologies Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Earnings Yield (Joel Greenblatt) % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
8.25 | 7.76 | 7.94 | -0.27 | -3.94 |
For the Pharmaceutical Retailers subindustry, Medicine Man Technologies's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Medicine Man Technologies's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Medicine Man Technologies's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Medicine Man Technologiess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as
Earnings Yield (Joel Greenblatt) | = | EBIT | / | Enterprise Value |
= | 17.26 | / | 217.3117238 | |
= | 7.94 % |
Medicine Man Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.6 Mil.
Medicine Man Technologies (OTCPK:SHWZ) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.
Thank you for viewing the detailed overview of Medicine Man Technologies's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Daniel Pabon | officer: General Counsel | 4880 HAVANA STREET, SUITE 201, DENVER CO 80212 |
Christine Jones | officer: Chief Legal Officer | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239 |
Forrest Hoffmaster | officer: CFO | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239 |
Nirup Krishnamurthy | director, officer: President | 4880 HAVANA STREET, SUITE 201, DENVER CO 80239 |
Kathy P Vrabeck | director | 625 WESTPORT PARKWAY, GRAPEVINE TX 76051 |
Jeff Garwood | director | 55 TABBY CIRCLE, DAUFUSKIE ISLAND SC 29915 |
Pratap Chandra Mukharji | director | 4880 HAVANA STREET, SUITE 201, DENVER CO 80239 |
Salim Husan Wahdan | director | 4880 HAVANA ST., STE. 201, DENVER CO 80239 |
Paul Joseph Montalbano | director | 4880 HAVANA ST., STE. 201, DENVER CO 80239 |
Brad Stewart | director | C/O SEMPER PARATUS ACQUISITION CORP., 767 THIRD AVENUE, 38TH FLOOR, NEW YORK NY 10017 |
Justin Dye | director, 10 percent owner, officer: CEO | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA STREET, SUITE 201, DENVER CO 80239 |
Jeffrey Alley Cozad | director, 10 percent owner | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239 |
Crw Capital Holdings Ii, Llc | 10 percent owner | 4740 W. MOCKINGBIRD LANE, STE 195579, DALLAS TX 75209 |
Crw Capital, Llc | 10 percent owner | 4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209 |
Crw Capital Cann Holdings, Llc | 10 percent owner | 4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209 |
From GuruFocus
By GuruFocus Research • 02-15-2024
By GuruFocus Research • 02-15-2024
By Marketwired • 07-01-2024
By PRNewswire • 08-08-2023
By Marketwired • 11-07-2024
By PRNewswire • 10-20-2023
By PRNewswire • 08-09-2023
By GuruFocus Research • 02-15-2024
By Marketwired • 12-04-2024
By GuruFocus Research • 02-15-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.